AE Wealth Management LLC Buys 1,314 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

AE Wealth Management LLC grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,184 shares of the exchange traded fund’s stock after acquiring an additional 1,314 shares during the period. AE Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,037,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. HBK Sorce Advisory LLC boosted its holdings in SPDR S&P Biotech ETF by 2.6% in the first quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock valued at $431,000 after acquiring an additional 113 shares during the last quarter. Intellectus Partners LLC boosted its stake in shares of SPDR S&P Biotech ETF by 1.0% in the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after purchasing an additional 113 shares during the last quarter. Pacific Center for Financial Services boosted its stake in shares of SPDR S&P Biotech ETF by 2.8% in the 1st quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock valued at $414,000 after purchasing an additional 118 shares during the last quarter. Kingsview Wealth Management LLC grew its position in shares of SPDR S&P Biotech ETF by 3.8% during the 1st quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock worth $332,000 after buying an additional 127 shares during the period. Finally, Bourgeon Capital Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 5.9% during the second quarter. Bourgeon Capital Management LLC now owns 2,427 shares of the exchange traded fund’s stock worth $225,000 after buying an additional 135 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $98.75 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm has a market capitalization of $7.53 billion, a P/E ratio of 11.47 and a beta of 1.11. The company’s 50 day simple moving average is $98.95 and its 200 day simple moving average is $93.90.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.